Clinical trial • Not applicable • Neurology|Other

[18F]PI-2620 for Corticobasal syndrome|Progressive supranuclear palsy|Behavioral variant frontotemporal dementia

Not applicable trial of [18F]PI-2620 for Corticobasal syndrome|Progressive supranuclear palsy|Behavioral variant frontotemporal dementia. 64 participants.

Overview

Trial Therapeutic Area
Neurology|Other
Trial Disease
Corticobasal syndrome|Progressive supranuclear palsy|Behavioral variant frontotemporal dementia
Trial Stage
Not applicable
Drug Modality
Radiopharmaceutical

Key dates

Initial CTIS Submission Date
14-07-2025
First CTIS Authorization Date
03-11-2025

Trial design

Not applicable trial across 1 site in Spain.

Target Sample Size
64

Eligibility

Recruits 64 No vulnerable populations selected; consent and assent handling not specified..

Vulnerable Population
No vulnerable populations selected; consent and assent handling not specified.

Recruitment

Planned Sample Size
64
Recruitment Window Months
28

Geography

Total Number Of Sites
1
Total Number Of Participants
64

Spain

Earliest CTIS Part Ii Submission Date
15-10-2025
Latest Decision Or Authorization Date
13-04-2026
Processing Time Days
180
Number Of Sites
1
Number Of Participants
64

Sites

Site Name
Complexo Hospitalario Universitario De Santiago
Department Name
Medicina Nuclear
Contact Person Name
Virginia Pubul
Contact Person Email
Virginia.Pubul.Nunez@sergas.es

Sponsor

Primary sponsor

Full Name
ZRO Imaging AB
Organisation Type
Hospital/Clinic/Other health care facility
Country Of Registered Address
Sweden

Investigational products

Investigational Product Name
[18F]PI-2620
Active Substance
[18F]PI-2620
Modality
Radiopharmaceutical

Related trials

Other published trials that may interest you.